Glaub Kathleen Sereda 4
4 · IO Biotech, Inc. · Filed Jun 13, 2023
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Glaub Kathleen Sereda
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-08+41,533→ 41,533 totalExercise: $2.08Exp: 2033-06-08→ Common Stock (41,533 underlying)
Footnotes (1)
- [F1]These options vest on June 8, 2024, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.